Keyword "RESVERATROL" found in the following publications:

THE STUDY OF OSTEOPROTECTIVE PROPERTIES OF NANOPARTICULATED FORMS OF RESVERATROL AND LOSARTAN
The study demonstrated that endothelial dysfunction of bone microvasculature and deterioration of regional blood flow in bone developed eight weeks ...
Abstract | Full text (PDF)
CORRECTION OF MORPHOFUNCTIONAL DISTURBANCES ARISING WHEN MODELLING PREECLAMPSIA WITH RESVERATROL AND NICORANDIL
Introduction: Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely amongst ...
Abstract | Full text (PDF)
MORPHOLOGICAL CHANGES IN GUM TISSUE DURING THIRAM INTOXICATION FOLLOWED BY CORRECTION WITH RESVERATROL AND SEA BUCKTHORN OIL
Background: The widespread use of pesticides can lead to a violation of the ecological balance between the ...
Abstract | Full text (PDF)
PROPERTIES OF NANO ENCAPSULATED L-ARGININE AND RESVERATROL IN WATER-SOLUBLE POLYMERS
This article analyzes properties of nano encapsulated L-arginine and resveratrol using a Nanoparticle Tracking Analysis method, and studies their supramolecular ...
Abstract | Full text (PDF)

Research Results in Biomedicine is included in the scientific database of the RINTs (license agreement No. 765-12/2014 dated 08.12.2014).

The journal is included in the list of peer-reviewed scientific publications recommended by the Higher Attestation Commission

The journal is indexed by the following scientific databases and platforms

Research Results in Biomedicine (ISSN 2658-6533)

The journal materials and website are licensed under Creative Commons «Attribution» 4.0 International.

The Founder: Federal State Autonomous Educational Institution of Higher Education "Belgorod National Research University"The Founder’s address: 85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

The Publisher: Federal State Autonomous Educational Institution of HigherEducation "Belgorod National Research University" The Founder’s address:85 Pobedy Street, Belgorod, the Belgorod region, 308015, Russia

Editors Office: chief editor Mikhail I. Churnosov, e-mail: RR_MedPharm@bsu.edu.ru, phone: +7 (4722) 30-14-03.

Regulations on the Journal

Certificate

Have questions?
You can write to us:

✉ Content manager

✉ Site administration

✉ Executive Secretary